Viewing Study NCT02974504


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-03-03 @ 6:44 PM
Study NCT ID: NCT02974504
Status: COMPLETED
Last Update Posted: 2018-07-23
First Post: 2016-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)
Sponsor: Dong-A ST Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module